Company Overview
About Henry Schein
Henry Schein is the world's largest provider of health care solutions to office-based dental and medical practitioners, founded in 1932 by Henry Schein in Queens, New York, and headquartered in Melville, New York. The company trades on Nasdaq (HSIC) and generated approximately $12.4 billion in net sales in 2024, serving over one million healthcare practitioners across more than 30 countries. Henry Schein operates through two segments: Health Care Distribution, supplying dental and medical consumables, equipment, and technology; and Technology and Value-Added Services, offering practice management software and digital dentistry solutions under brands like Dentrix, Dexis, and Axium.
Business Model & Competitive Advantage
The company suffered a major cybersecurity breach in October 2023 when the ALPHV/BlackCat ransomware group targeted its distribution systems, disrupting operations for several months and resulting in data theft affecting over 166,000 individuals. By mid-2024, Henry Schein had restored full operations and invested significantly in cybersecurity infrastructure, emerging with hardened network segmentation, enhanced endpoint detection, and new incident response protocols. The OneSource platform integrates procurement, practice management, and digital imaging into a unified workflow for dental and medical offices, creating switching costs that underpin recurring revenue.
Competitive Landscape 2025–2026
In 2025-2026, Henry Schein competes primarily with Patterson Companies (PDCO) in dental distribution and McKesson in medical supply. The digital dentistry revolution—encompassing intraoral scanners, CAD/CAM milling, and AI-assisted diagnosis—represents a significant growth vector, with Henry Schein's technology segment growing faster than distribution. Strategic investments in specialty dental networks and DSO (Dental Service Organization) partnerships aim to capture the consolidating dental market. The company also expanded its animal health distribution through Covetrus until its 2022 sale, allowing sharper focus on human health markets.
The Henry Schein Story
Founders
Company Timeline
Major milestones in Henry Schein's journey
Leadership Team
Meet the leaders behind Henry Schein
Stanley M. Bergman
Stanley Bergman has served as Chairman and CEO of Henry Schein since 1989, transforming the company from a $225 million barely profitable business into a global healthcare solutions giant with nearly $13 billion in annual revenue. Born in South Africa, Bergman came to New York in 1976 as an accountant, joined Henry Schein in 1980, and was promoted to CFO before becoming CEO. Under his 35+ year leadership, the company's market cap expanded from $290 million at its 1995 IPO to approximately $9 billion. He will retire as CEO at the end of 2025 while continuing as Chairman.
Ronald N. South
Ronald N. South has served as Senior Vice President and Chief Financial Officer of Henry Schein since 2022, overseeing the company's financial strategy, reporting, and capital allocation. He plays a key role in the company's strategic planning and has been instrumental in navigating the 2024-2025 restructuring and KKR investment.
Michael S. Ettinger
Michael S. Ettinger has been Chief Operating Officer and Executive Vice President of Henry Schein since 2022, responsible for operational excellence across the company's global distribution network and value-added services. He oversees the company's day-to-day operations and execution of strategic initiatives.
Andrea Albertini
Andrea Albertini was appointed CEO of the Global Distribution Group in 2024, with additional responsibility for the Global Technology Group. In this role, he leads the company's largest segment, which generated $10.8 billion in sales in 2024, overseeing dental and medical distribution as well as technology solutions.
Tom Popeck
Tom Popeck was appointed CEO of the Healthcare Specialties Group (HSG) in 2024, leading the segment that generated $1.4 billion in sales. He is responsible for the company's specialty healthcare products business and strategic growth initiatives in this high-margin segment.
Steve Boggan
Steve Boggan was appointed co-CEO of the Global Oral Reconstruction Group (GORG) in 2024, sharing leadership responsibility with Bianka Wilson. He oversees operations and strategic initiatives in the oral reconstruction and specialty dental equipment segment.
Bianka Wilson
Bianka Wilson was appointed co-CEO of the Global Oral Reconstruction Group (GORG) in 2024, sharing leadership with Steve Boggan. She brings extensive experience in healthcare and leads strategic initiatives for the oral reconstruction business.
Robert J. Hombach
Robert J. Hombach joined the Henry Schein Board as an independent director in January 2025 in connection with KKR's strategic investment. He brings extensive financial and strategic experience in healthcare, providing valuable governance oversight during the company's transformation.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Henry Schein is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $12400M in revenue, Henry Schein operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Henry Schein with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Henry Schein? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Henry Schein Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Henry Schein vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →